diseases, age at first pap smear, pap smear frequency, use of oral contraceptives and the number of pregnancies. Results: Overall, 600 respondents were eligible for the analysis, consisting of 465 patients (44.0±16.3 years) and 135 controls (44.0±13.2 years). More than 5 sexual partners increased the risk of acquiring HPV infections up to 2.52-fold (95%CI: 1.34-4.74), while smoking or an early sexual debut (≤ 18 years) raised it by about a factor of 1.62. Higher levels of education were associated with a protective effect. The overall rate of individuals at high risk with more than 5 sexual partners and at least another additional factor corresponded to 26.3% (158 out of 600). The proportion of subjects with an average risk (respondents with less than 5 partners and at least another additional factor) amounted to 53.2% (319 out of 600). ConClusions: Analysis of risk factors can be used as part of the economic assessment of other effective HPV vaccination strategies, including an immunization programme for pre-adolescents of both sexes in Italy.
objeCtives: To ascertain the epidemiological factors associated with Acinetobacter infections and the resistance pattern of this organism. Methods: A cross sectional, observational, retrospective study was carried out, over a period of 6 months in a tertiary care hospital (Oct 2012 to Mar 2013 . The data collected was analysed to understand the pattern with respect to patient demographics, prescription patterns, comorbidities as risk factors to infection, and resistance patterns. Results: Based on this study it was observed that surgery was not a risk factor for Acinetobacter infections. Male patients had a greater risk of A. baumannii infections. Age distribution of infections was mainly in 41-60 years and 61-80 years. The bacteria were found to be resistant to almost all categories of drugs except colistin, and tigecycline. The mean length of stay of a patient of A.baumanni infection was found to be 23.51±27.97 days. Tigecycline and cefixime were the most prescribed antibiotics (97.9%) in the present study. Cefoperazone-sulbactam was found to have an antibiotic action against the bacterium. ConClusions: This study concluded that male patients were at a greater risk of A.baumannii infections. However surgery could not be considered as a risk factor for the same. Length of stay of patients was on average 23.51±27.97 days. This study showed tigecycline and cefixime were the most prominently used antibiotic. The strain in this study was resistant to almost all cephalosporins except Cefoperazone-Sulbactam which had activity in 57.14% of the samples tested.
INfeCtIoN -Cost Studies

PIN17 Budget ImPACt ANAlISIS of SwItCHINg from dPt ANd moNovAleNt vACCINeS to dtAP-IPv-HIB ComBINed vACCINe INto ruSSIAN ImmuNIzAtIoN SCHedule
Kulikov A. 1 , Akimova Y. I. 2 1 First moscow state medical University named after I.m. sechenov, moscow, Russia, 2 First moscow medical academy named after I.m. sechenov, moscow, Russia objeCtives: The current Russian immunization program for children from 0 to 20 months is carried mainly by DPT and monovalent vaccines. In addition, vaccination against Hib infection so far is only available for children at risk (approx. 20%). Introduction of DTaP-IPV-Hib combined vaccine could reduce the number of injections received by the child and increase coverage against Hib infection from 20% to 97%. The objective of this evaluation is to calculate the incremental of switching from current monovaccines and DTP-based routine immunization schedule using a pentavalent combined vaccine DTaP-IPV-Hib through a different schemes. Methods: A budget impact analysis of the switching to the different schemes DTaP-IPV/Hib vaccine is performed on the suggested Markov model. The three alternatives (against current immunization program) are compared: a 3+1DTaP-IPV-Hib immunization (Scheme P), a mixed DTwP / DTaP-IPV-Hib immunization (Scheme mix) and a potential scenario -the current scheme, but with expanded (97%) Hib coverage-Scheme 1.The cohort of infants born in 2011 year is followed over their lifetime. Direct and indirect medical costs are measured from the perspective of the public payer. For reference, accepted exchange rate is 1€ = 41 rub. Results: The budget impact analysis has shown that the switching from the current vaccination schedule for one of the alternative require additional funds in the amount of 705 Liver and lungs was most common site of infection (81.1% and 13.5% of cases, respectively) Spleen was (2.0%). Cysts were found in sites like Pancreas, Ovary and kidney were (3.4 %) ConClusions: Hydatid disease is a Health problem affecting young Libyan population. The mean age of the patients was (2-40) years and more common in women) housewives) and students, the most common site of HD found in liver followed by lungs. Further studies are required to find the etiologic factors of HD in different areas in Libya.
PIN14
PredICtor fACtorS for tHe PreSeNCe of PoSt HerPetIC NeurAlgIA At 3 moNtHS IN HerPeS zoSter PAtIeNtS Aged 50 ANd over IN ItAly: reSultS from A gP-BASed oBServAtIoNAl ProSPeCtIve multICeNter Study
Bricout H. 1 , Perinetti E. 2 , Marchettini P. 3 , Ragni P. 4 , Zotti C. 5 , Gabutti G. 6 , Volpi A. 7 , Franco E. 8 1 sanofi pasteur msD, Lyon, France, 2 sanofi pasteur msD, Roma, Italy, 3 IsTITUTO sAN RAFFAELE DI mILANO E scUOLA UNIVERsITARIA DELLA sVIZZERA ITALIANA, milan, Italy, 4 DIR. sANITARIA AsL REGGIO EmILIA, Reggio Emilia, Italy, 5 UNIVERsITA' DEGLI sTUDI DI TORINO, Turin, Italy, 6 Hygiene and public Health, chiavari (Genova), Italy, 7 Università di Roma Tor Vergata, Roma, Italy, 8 UNIVERsITA' DEGLI sTUDI DI ROmA TOR VERGATA, Roma, Italy objeCtives: To identify predictors for the presence of Post Herpetic Neuralgia (PHN) at 3 months in Herpes Zoster (HZ) patients aged 50 and over in Italy. Methods: General Practitioners (GPs) from regions throughout Italy included immunocompetent patients over 50 years old with a new HZ diagnosis and followed them during 6 months with visits (V) at 0, 1, 3 and 6 months. Occurrence and level of pain using a 0 to 10 visual analogic scale (VAS), clinical symptoms, patients' quality of life (QoL) and their health care resources utilization were recorded. A multivariate regression model was run to assess the predictor factors for the presence of PHN at 3 months. Univariate analysis was first undertaken on each variable to identify possible associations with PHN (level of significance, 25%) to be considered in the multivariate regression model. Results: From March 2009 to July 2010, 108 GPs included 413 patients (148 Males and 265 Females) with HZ aged 67.9 y± 10.7 years. Most of them (89.6%) had pain at V0 (VAS score:5.8/10) and 91.5% received systemic antivirals, 70% within 72 hours after rash onset. During the follow-up, 52 patients consulted at least one specialist (dermatologist, neurologist, ophthalmologist…) and no cases were hospitalized. At 3 month, 20.6% presented PHN (VAS score: 3.7/10), and still 9.2% at 6 months (VAS score: 3.7/10). By logistic regression analysis a VAS score over 3, the presence of more than 50 vesicles and the gender male were the main predictive factors at the initial visit that were significantly associated with the presence of PHN at 3 months. ConClusions: Even if most of patients with HZ received the standard of care, many experienced intense and long-lasting pain. This study identified specific factors at presentation that could help identify patients who will develop PHN.
PIN15 rISk fACtorS INflueNCINg tHe vIrAl trANSmISSIoN ANd tHe PoteNtIAl develoPmeNt of HPv-INduCed PAtHologIeS
